Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152).

导出 LinkOut

翻译打印收藏纠错

作者： Apoorva,Munigela ^[1] ; Divya Tej,Sowpati ^[2] ; Sasikala,M ^[3] ; Sofia,Banu ^[2] ; Archana Bharadwaj,Siva ^[4] ; Jagadeesh Kumar,V ^[2] ; Chandrasekhar,Nutalapati ^[1] ; Ravikanth,Vishnubhotla ^[1] ; Anand,Kulkarni ^[3] ; Payel,Mukherjee ^[1] ; Lamuk,Zaveri ^[2] ; G V,Rao ^[2] ; Karthik Bharadwaj,Tallapaka ^[1] ; D,Nageshwar Reddy ^[2] ; CCMB COVID-19 Team, AIG Hospitals COVID-19 Vaccine Study Team ^[1]

作者单位： AIG Hospitals, Internal Medicine, Gachibowli, Hyderabad, Telangana, India. ^[1] CSIR - Centre for Cellular and Molecular Biology, Habsiguda, Hyderabad, Telangana, India. ^[2] Asian Healthcare Foundation, Gachibowli, Hyderabad, Telangana, India. ^[3] Academy of Scientific and Industrial Research, Ghaziabad, India. ^[4]

关键词 COVID-19 Covaxin Covishield SARS-CoV-2

DOI 10.1016/j.ijregi.2022.08.016

PMID 36090517

发布时间 2022-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

IJID regions

2022年5卷

104-110页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152).

IJID regions

相似文献

IJID regions

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152).

IJID regions

相似文献

IJID regions

相关期刊

检索历史清除